White House secures deals for 200 million more Covid vaccine doses


Every human life is precious and sacred and saving one is like the saving of the whole of humanity. (Al Quran 5:32/33)

Source: CNBC


  • President Joe Biden announced Thursday that his administration signed deals for 200 million more doses of Covid-19 vaccine, bringing the U.S. total to 600 million.
  • In addition to securing more doses for states, the Biden administration is using the military to help administer doses and is setting up mass vaccination centers across the country.

President Joe Biden announced Thursday that his administration has secured deals for another 200 million doses of Covid-19 vaccine, bringing the U.S. total to 600 million.

“Just this afternoon, we signed the final contracts for 100 million more Moderna and 100 million more Pfizer vaccines,” Biden said Thursday while on a tour at the National Institutes of Health, adding the U.S. will have enough supply for 300 million Americans by the end of July.

The Washington Post first reported the news. Earlier, White House chief of staff Ron Klain appeared to confirm the news, retweeting the Post story from his official White House Twitter account.

Because both Pfizer’s and Moderna’s authorized vaccines require two doses given about three to four weeks apart, the total of 600 million doses would be enough to inoculate 300 million people.

Biden is trying to pick up the pace of vaccinations in the U.S. after a slower-than-expected rollout under former President Donald Trump’s administration. Roughly 34.7 million out of some 331 million Americans have received at least their first dose of Covid vaccine, according to data compiled by the Centers for Disease Control and Prevention. And 11.2 million of those people have already gotten their second shot.

The schedule for delivery of the additional doses was not immediately clear.

Each company will leverage U.S.-based manufacturing capacity “to fill, finish and ship vials as the bulk material is produced,” the Department of Health and Human Services said in a separate statement.

Pfizer already has a deal with the U.S. to deliver 200 million doses. The company said earlier this month that it planned to finish those shipments by May, earlier than its initial forecast of July. Moderna also has a deal with the U.S. for 200 million doses.

Read further

Categories: Vaccine

7 replies

  1. Canada has secured the world’s largest number of potential Covid vaccine doses per capita – but it’s struggling to get its hands on some of those doses and to get jabs into arms.

    On Friday, Prime Minister Justin Trudeau promised an “enormous increase” in doses coming to Canada of both the Pfizer and Moderna vaccines, the only two currently authorised for use in the country.

    He is under pressure from critics who say he has not delivered vaccines fast enough, and has promised that all Canadians who want a vaccine will get one by the end of September.

    Canada’s inoculation drive began 14 December, and the country has so far given just over 1.18 million doses. It currently stands at 40 in global rankings of doses per 100 people, according to data compiled by Bloomberg.

    Just over three out of 100 Canadians have received at least one dose, compared to about 14 in the US and 21 in the UK.


  2. Claims on social media that the Covid vaccine could affect female fertility are unfounded, experts have said.

    Posts have incorrectly suggested the Pfizer vaccine could cause infertility in women, or cause their bodies to attack the placenta.

    But there is no “plausible biological mechanism” by which the vaccine could affect your fertility, says Prof Lucy Chappell, a professor in obstetrics at King’s College London and spokesperson for the Royal College of Obstetricians and Gynaecologists.

    How does the vaccine work?
    The vaccine works by sending a message to the body with a blueprint, allowing it to manufacture a small, harmless fragment of the coronavirus’s distinctive “spike”.

    This prompts your immune system to kick into action, producing antibodies and white blood cells to fight off the virus – and recognising it if you encounter it again.

    It can’t give you the virus, and it has no way of affecting your own genetic information.

    These “messenger particles” are extremely short-lived: they deliver their message and then they are destroyed. That’s why the Pfizer vaccine in particular has to be stored so carefully – genetic material falls apart and becomes useless very easily.


  3. The U.S. has administered 50.1 million doses of Covid-19 vaccine in the two months since rollout of the shots began, according to data compiled by the Bloomberg Vaccine Tracker.

    With the milestone, 36.8 million people in the U.S. have gotten at least one dose of a vaccine, and of those 12.8 million have been fully vaccinated.

    More than 1.7 million doses a day in the U.S. are being administered, based on a seven-day average.


  4. Some Covid-19 patients are experiencing shortness of breath, fatigue, headaches and “brain fog” for months to nearly a year after their initial illness. Now, global medical experts are working to better diagnose and treat them for what they are tentatively calling “long Covid.”

    Earlier this week, the World Health Organization hosted a global meeting with “patients, clinicians and other stakeholders” to advance the agency’s understanding of what’s medically referred to as post-Covid condition, also known as long Covid, WHO Director-General Tedros Adhanom Ghebreyesus said on Friday.

    The gathering was the first of many to come. The goal will be to eventually create an “agreed clinical description” of the condition so doctors will be able to diagnose and effectively treat patients, he said. Given how many people have been infected with the virus globally — nearly 108 million people as of Friday — Tedros warned it’s likely many will experience these lingering symptoms.

    “This illness affects patients with both severe and mild Covid-19,” Tedros said during a press briefing at the agency’s headquarters in Geneva. “Part of the challenge is that patients with long Covid could have a range of different symptoms that can be persistent or can come and go.”


  5. More data from Israel’s vaccination programme is suggesting the Pfizer jab prevents 94% of symptomatic infections.

    This indicates the vaccine is performing just as well in a larger population as it did in the clinical trials.

    It is proving highly effective at preventing illness and severe disease among all age groups, according to public health doctor Prof Hagai Levine.

    “High vaccination coverage of the most susceptible groups” was key, he said.

    Israel’s largest health fund Clalit looked at positive tests in 600,000 vaccinated people and the same number of unvaccinated people, matched by age and health status.

    It found 94% fewer infections among the vaccinated group.

    This was based on test results in people’s medical records, usually taken if they had symptoms or were a close contact of someone who had tested positive.

    And the vaccine prevented almost all cases of serious illness.

    This pattern was the same in all age groups – including the over-70s, who may have been under-represented in clinical trials.

    The data has not yet been formally published.


  6. The fear that a vaccine will somehow change your DNA is one we’ve seen aired regularly on social media.

    The BBC asked three independent scientists about this. They said that the coronavirus vaccine would not alter human DNA.

    Some of the newly created vaccines, including the one now approved in the UK developed by Pfizer/BioNTech, use a fragment of the virus’s genetic material – or messenger RNA.

    “Injecting RNA into a person doesn’t do anything to the DNA of a human cell,” says Prof Jeffrey Almond of Oxford University.

    It works by giving the body instructions to produce a protein which is present on the surface of the coronavirus.

    The immune system then learns to recognise and produce antibodies against the protein.


  7. London (CNN)New data shows that the first dose of the Pfizer/BioNTech Covid-19 vaccine “provides high levels of protection against infection and symptomatic disease,” Public Health England (PHE) said in a press release on Monday.

    PHE’s Siren Study, which was carried out on healthcare workers aged under the age of 65, found that one dose of the vaccine reduced the risk of infection by 72% after three weeks, while two vaccine doses reduced the risk of infection by 85%. This high level of protection extended to the B.1.1.7 coronavirus variant first identified in the UK in December.
    Health workers were tested for Covid-19 infection every two weeks using PCR tests and twice a week with lateral flow tests, Dr. Susan Hopkins, strategic response director at PHE, explained, meaning “there was a lot of asymptomatic testing,” she said.
    “Overall we are seeing a really strong effect to reducing any infection: asymptomatic and symptomatic,” Hopkins said during a press conference held by the UK’s Science Media Centre on Monday.


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.